10-Q 1 ammj10q081716.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

 

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2016.

 

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______.

 

Commission File Number 000-26108

AMERICAN CANNABIS COMPANY, INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
    94-2901715
(I.R.S. Employer
Identification No.)

 

5690 Logan St. Unit A
Denver, Colorado
(Address of principal executive offices)

   

 

80216
(Zip Code)

(303) 974-4770
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X]    No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X]   No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

             
Large accelerated filer [ ]   Accelerated filer [ ]   Non-accelerated filer [ ]
 (Do not check if a
smaller reporting company)
  Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ]    No [X]

On August 17, 2016, 46,663,474 shares of common stock were outstanding.   
 

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION Page
     
Item 1. FINANCIAL STATEMENTS (Unaudited): 1
     
CONDENSED CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2016 AND DECEMBER 31, 2015 1
     
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX   
MONTHS ENDED JUNE 30, 2016 AND 2015. 2
     
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED  
JUNE 30, 2016 AND JUNE 30, 2015 3
     
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 4
     
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND   
     
RESULTS OF OPERATIONS 11
     
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 17
     
Item 4. CONTROLS AND PROCEDURES 17
     
PART II. OTHER INFORMATION    
     
Item 1. LEGAL PROCEEDINGS 18
     
Item 1A. RISK FACTORS 18
     
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 18
     
Item 3. DEFAULTS UPON SENIOR SECURITIES 19
     
Item 5. OTHER INFORMATION 19
     
Item 6. EXHIBITS 19
     
SIGNATURES   20

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

AMERICAN CANNABIS CORPORATION
BALANCE SHEETS  (Unaudited)
 
         
      June 30, 2016       December 31, 2015  
ASSETS                
Current Assets                
       Cash and equivalents   $ 228,654     $ 555,780  
       Accounts receivable, net of allowance $2,486 and $8,419, respectively     151,736       48,285  
       Deposits     6,500       9,345  
       Inventory     67,728       67,435  
       Prepaid expenses and other current assets     50,763       32,117  
Total Current Assets     505,381       712,962  
                 
Property and equipment - net     12,633       13,448  
                 
Other Assets                
       Deposits     4,500       4,500  
Total Other Assets     4,500       4,500  
                 
TOTAL ASSETS   $ 522,514     $ 730,910  
                 
LIABILITIES AND SHAREHOLDER'S DEFICIT                
Current Liabilities                
       Accounts payable   $ 71,843     $ 218,334  
       Advances from clients     115,550       220,966  
       Convertible note, net of discount of $10,935 and $11,248, repectively     139,065       60,252  
       Accrued and other current liabilities     71,750       93,468  
Total Current Liabilities     398,208       593,020  
                 
Total Liabilities     398,208       593,020  
                 
Commitments and contingencies                
                 
Shareholder's deficit                
Common stock, $0.00001 par value;  100,000,000 shares authorized; 46,585,814 and 44,808,731 issued and outstanding at June 30, 2016 and December 31, 2015, respectively     465       448  
Additional paid-in capital     4,353,439       4,268,708  
Accumulated deficit     (4,229,598 )     (4,131,266 )
Total Shareholder's deficit     124,306       137,890  
                 
TOTAL LIABILITIES AND SHAREHOLDER'S DEFICIT   $ 522,514     $ 730,910  

 

The accompanying notes are an integral part of these unaudited consolidated financial statements. 

AMERICAN CANNABIS CORPORATION
RESULTS OF OPERATIONS
(UNAUDITED)
                 
    For the three months ended June 30,   For the six months ended June 30,
    2016   2015   2016   2015
Revenues                                
     Consulting Services   $ 211,863     $ 268,488     $ 459,473     $ 464,058  
     Product and equipment     231,785       200,257       524,579       448,354  
Total Revenues     443,648       468,745       984,052       912,412  
                                 
Cost of Revenues                                
     Cost of consulting services     51,278       88,632       99,800       146,483  
     Cost of products and equipment     145,848       176,347       380,857       401,998  
Total Cost of Revenues     197,126       264,979       480,657       548,481  
                                 
Gross Profit     246,522       203,766       503,395       363,931  
                                 
Operating expenses                                
     General and administrative     307,953       130,454       531,440       252,578  
     Investor Relations     893       56,286       18,068       187,702  
     Selling and marketing     19,662       113,224       40,477       207,529  
     Research and development     1,413       11,350       1,413       41,722  
Total Operating expenses     329,921       311,314       591,398       689,531  
                                 
Loss from Operations     (83,399 )     (107,548 )     (88,003 )     (325,600 )
                                 
Other Income (expense)                                
    Gain on debt extinguishment     0       72,771       0       72,771  
     Interest Income (expense)     (1,376 )     (8,837 )     (10,329 )     (17,623 )
Total Other Income (expense)     (1,376 )     63,934       (10,329 )     55,148  
                                 
Net Loss before taxes     (84,775 )     (43,614 )     (98,332 )     (270,452 )
Income Tax expense (benefit)     0       0       0       0  
                                 
NET LOSS   $ (84,775 )   $ (43,614 )   $ (98,332 )   $ (270,452 )
                                 
Basic and diluted net loss per common share *   ($ 0.00 )   ($ 0.00 )*   ($ 0.00 )*   ($ 0.01 )
                                 
Basic and diluted weighted average common shares outstanding     46,375,168       45,752,033       45,628,580       45,275,183  
                                 
* denotes a loss of less than $(0.01).                                

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

AMERICAN CANNABIS CORPORATION
STATEMENT OF CASHFLOWS
FOR THE 6 MONTHS ENDED JUNE 30, 2016 AND 2015
(UNAUDITED)
         
      2016       2015  
CASH FLOWS FROM OPERATING ACTIVITIES:   $ (98,332 )   $ (270,452 )
Net loss                
Adjustments to reconcile net loss) to net cash (used in)                
operating activities:                
  Bad debt expense     13,344       0  
  Depreciation     2,477       1,474  
  Amortization of discount on convertible notes payable     10,372       17,704  
  Stock-based compensation to employees     14,422       80,394  
  Stock-based compensation to service providers     9,198       107,385  
  Gain on debt extinguishment     —         (72,771 )
  Changes in operating assets and liabilities                
     Accounts receivable     (116,795 )     (44,842 )
     Deposits     2,845       102,202  
     Inventory     (293 )     (25,600 )
     Prepaid expenses and other current assets     (18,646 )     (5,606 )
     Advances from clients     (105,416 )     (144,115 )
     Accrued and other current liabilities     (31,214 )     (1,511 )
     Accounts payable     (146,491 )     80,370  
Net Cash used in Operating Activities     (464,529 )     (175,368 )
                 
CASH FLOWS USED INVESTING ACTIVITIES:                
  Purchases of property and equipment     (1,662 )     (12,332 )
Net Cash Used in Investing Activities     (1,662 )     (12,332 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
  Proceeds from issuance of convertible notes payable     139,065       0  
  Proceeds from issuance of common shares     0       250,000  
Net Cash Provided by Financing Activities     139,065       250,000  
                 
NET (DECREASE) INCREASE IN CASH     (327,126 )     62,300  
                 
CASH AT BEGINNING OF PERIOD     555,780       165,213  
                 
CASH AT END OF YEAR   $ 228,654     $ 227,513  
                 
Supplemental disclosure of cash flow information:                
  Cash paid during the period for interest   $ —       $ (80 )
  Cash paid (received) during the period for income taxes, net   $ —       $ —    
Non-Cash Investing and financing activities with Debt Conversion                
   Conversion of notes payable to shares of common stock   $ 71,500.00     $ —    
   Payment of notes payable via Conversion to shares of common stock   $ (71,500.00 )   $ —    

The accompanying notes are an integral part of these unaudited consolidated financial statements.

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2016 and 2015
(Unaudited)

 

Note 1. Description of the Business

 

American Cannabis Company, Inc. and its subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, designs industry-specific products and facilities, and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Accounting

The financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company has elected a fiscal year ending on December 31. Certain balance sheet reclassifications have been made to prior period balances to reflect the current period’s presentation format; such reclassifications had no impact on the Company’s consolidated statements of operations or consolidated statements of cash flows and had no material impact on the Company’s consolidated balance sheets.

 

Reclassifications

 

Prior year amounts have been reclassified to conform to the current year presentation.

 

Use of Estimates in Financial Reporting

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are deemed to be necessary. Significant estimates made in the accompanying financial statements include but are not limited to following: those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, contingencies and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements.

 

Unaudited Interim Financial Statements

The accompanying unaudited financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X.  Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Significant Clients and Customers  

For the three months ended June 30, 2016, four customers individually accounted for $494,003 of the Company’s total revenues; these customers accounted for approximately 79% of the Company’s total revenues for the period. For the six months ended June 30, 2016, six customers individually accounted for $834,907 of the Company’s total revenues; these customers accounted for approximately 71% of the Company’s total revenues for the period.

 

For the three months ended June 30, 2015, two customers individually accounted for 10% or more of the Company’s revenues; these customers accounted for approximately 63% of the Company’s total revenues for the period. For the six months ended June 30, 2015, three customers individually accounted for 10% or more of the Company’s revenues; these customers accounted for approximately 70% of the Company’s total revenues for the period. For the three months ended June 30, 2014, three customers individually accounted for 10% or more and 65% in aggregate of the Company’s total revenues. For the six months ended June 30, 2014, three customers individually accounted for 10% or more and 66% in aggregate of the Company’s total revenues. 

 

Net Income (Loss) Per Common Share

The Company reports net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

 

Due to the Company’s net losses for the three and six months ended June 30, 2016 and June 30, 2015, any potentially dilutive shares outstanding as of June 30, 2016 and June 30, 2015 respectively, were not presented in the EPS computations, as their effect would have been antidilutive.

 

Recent   Accounting Pronouncements

 

The Company has reviewed all the recently issued, but not yet effective, accounting pronouncements and it does not believe any of these pronouncements will have a material impact on the Company.

 

Reclassifications

 

Prior year amounts have been reclassified to conform to the current year presentation.

 

Note 3. Accounts Receivable, net

 

Accounts receivable, net, was comprised of the following as of June 30, 2016 and December 31, 2015:

 

      30-Jun-16       31-Dec-15  
                 
Gross accounts receivable   $ 154,222     $ 56,704  
Less: allowance for doubtful accounts     (2,486 )      (8,419 ) 
Accounts receivable, net   $ 151,736     $ 48,285  

 

The Company had bad debt expense during the six months ended June 30, 2016 and 2015 of $13,344 and $0, respectively. During the six months ended June 30, 2016 and 2015, the Company wrote-off old receivables and their related allowances for bad debts of $19,277 and $0, respectively.

 

Note 4. Deposits

 

Deposits were comprised of the following as of June 30, 2016 and December 31, 2015:

 

 

Inventory deposits as of June 30, 2016 and December 31, 2015 reflect down payments made to suppliers or manufacturers under inventory purchase agreements.

 

Note 5. Inventory

 

Inventory as of June 30, 2016 and December 31, 2015 of $67,728 and $67,435, respectively, was fully comprised of finished goods.

 

Note 6. Prepaid expenses and other current assets

 

Prepaid expenses and other current assets was comprised of the following as of June 30, 2016 and December 31, 2015:

 

      30-Jun-16       31-Dec-15  
                 
Inventory deposits   $ 6,500     $ 9,345  
Operating lease deposits included in other Assets     4,500       4,500  
Deposits   $ 11,000     $ 13,845  

 

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following as of June 30, 2016 and December 31, 2015:

 

      30-Jun-16       31-Dec-15  
Office equipment   $ 9,275     $ 7,472  
Furniture and fixtures     8,635       8,777  
Machinery and equipment     2,337       2,336  
Property and equipment, gross     20,247       18,585  
Less: accumulated depreciation     (7,614 )     (5,137 )
Property and equipment, net   $ 12,633     $ 13,448  

 

The Company recorded depreciation expense of $1,256 and $758 during the three months ended June 30, 2016 and 2015, respectively. During the six months ended June 30, 2016 and 2015, the Company recorded depreciation expense of $2,470 and $1,474, respectively.

 

Note 8. Notes Payable

 

As of June 30, 2016 and December 31, 2015, the Company reflected convertible notes payable as follows:

 

      Principal balance       Loan Discount       Accrued Interest       Total  
Balance as of December 31, 2015   $ 71,500       (11,248           $ 60,252  
Issued in the period     150000       (10,235     473       140,238  
Converted into shares of common shares     (71,500     10,075               (61,425
Balance as of June 30, 2016   $ 150,000       (11,408   $ 473     $ 139,065  

 

The Company had convertible debentures which were originally issued on April 24, 2014, maturing on April 24, 2016, paid zero interest, and were convertible until maturity at the holders’ discretion into shares of the Company’s common stock at $0.08 per share. On April 11th, 2016, the maturity date on this note was renegotiated to April 24th, 2018. On April 12, 2016, the Company received notice of a partial conversion of this note in the amount of $58,000 that was converted into 725,000 shares of common stock at a price of $0.08 per share. On May 6, 2016, the Company received notice for the conversion of the balance of the note in the amount of $13,500 that was converted into 168,750 shares of common stock at a price of $0.08 per share. Based on this conversion, as of June 30, 2016, the Company had remaining convertible debentures in the total amount of $0, and any unamortized debt discount remaining on the date of conversion was amortized in full to interest expense.

 

On June 23, 2016, the Company entered into two convertible promissory notes: one for $50,000 and one for $330,000  . As of the date of this filing, the Company received $150,000 in proceeds recorded a discount of $10,935. The maturity date for each note is February 14, 2017. Each note pays 8% fixed interest and is convertible at the holder’s discretion into shares of the Company’s common stock at a fixed price of $0.1135 per share. On August 4, 2016 the notes were amended and restated to delete portions of the notes that originally provided for a conversion formula used to determine the price per share and to delete a provision that provided for repayment of the notes through a separate investment agreement providing for the Company to sell its registered shares to an investor (See Subsequent Events Note 14).

   

Note 9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities was comprised of the following at June 30, 2016 and December 31, 2015:

 

      30-Jun-16       31-Dec-15  
                 
Accrued payroll liabilities   $ 9,808     $ 18,185  
Accrual for products sold and shipped (in transit)     46,417       64,050  
Other accruals     15,525       11,233  
Accrued and other current liabilities   $ 71,750     $ 93,468  

 

Note 10. Related Party Transactions

 

During the six months ended June 30, 2016, the Company incurred $14,500 of expense for accounting services payable to JDE Development LLC, a company in which Jesus M Quintero, the Company’s Chief Financial Officer, is an owner.   

 

Note 11. Commitments and Contingent Liabilities

 

On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock per month for the three-month term payable on May 31, 2016, subject to adjustment for actual hours of service rendered. On June 1, 2016, the Company and Mr. Johnson agreed to an extension of the consulting engagement for an additional one-month term, ending on June 30, 2016. Mr. Johnson provided additional services and upon the termination of the engagement on June 30, 2016, the Company agreed to issue Mr. Johnson 87,600 shares of common stock as a final payment for services rendered from inception through June 30, 2016 at a value of $9,198. As of the date of this filing the shares have not been issued.

 

On January 20, 2016, we were named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit originally sought damages of $100,000 related to an employment contract. The Company filed a motion with the Court to dismiss the complaint and refer the Company and Mr. Baroud to arbitration. On May 18, 2016 the Court granted the Company’s motion and dismissed Mr. Baroud’s complaint. Mr. Baroud has not pursued arbitration as of the date of this filing.

 

Note 12. Stock-based Compensation

 

Warrants

 

As of June 30, 2016 and December 31, 2015, the Company issued fully-vested warrants to the Company’s independent board member to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share were outstanding, exercisable within five (5) years of the date of issuance on November 19, 2014. The grant date fair value of the warrants, as calculated based on the Black-Scholes valuation model, was $0.59 per share. There were no outstanding unvested warrants or new issuances of warrants during the three months ended June 30, 2016; consequently, no stock-based compensation expense associated with warrant was recorded during the six months ended June 30, 2016.

 

As of June 30, 2016 and December 31, 2015, as the exercise price per share exceeded the price per share of our common shares, there was no aggregate intrinsic value of outstanding warrants. As of June 30, 2016 and December 31, 2015, the warrants had 3.6 and 3.3 years remaining until expiration, respectively. No warrants were issued or outstanding during or preceding the six months ended June 30, 2016. 

 

Stock

Options

 

In addition to the warrants as described above, the Company’s independent board member shall be eligible to receive options for 400,000 shares of common stock under the Company’s incentive plan, as and when duly approved by the Board of Directors.

 

Stock Issuable in Compensation for Professional Services

 

From time to time, the Company enters into agreements whereby a professional service provider will be compensated for services rendered to the Company by shares of common stock in lieu of cash.

 

On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock per month for the three-month term payable on May 31, 2016, subject to adjustment for actual hours of service rendered. On June 1, 2016, the Company and Mr. Johnson agreed to an extension of the consulting engagement for an additional one-month term, ending on June 30, 2016. Mr. Johnson provided additional services and upon the termination of the engagement on June 30, 2016, the Company agreed to issue Mr. Johnson 87,600 shares of common stock as a final payment for services rendered from inception through June 30, 2016 at a value of $9,198 (See Note 11). . As of the date of this filing the shares have not been issued.

 

Note 13. Stockholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding during the six months ended June 30, 2016 and 2015, respectively.

 

Common Stock

 

American Cannabis Company, Inc. is authorized to issue 100,000,000 common shares at $0.00001 par value per share.

 

Note 14. Subsequent Events

 

The Company previously entered into an Investment Agreement with Tangiers Global, LLC, a Wyoming Limited Liability Company, on June 23, 2016.

 

On August 4, 2016, the Company and Tangiers Global, LLC, amended and restated the two fixed convertible promissory notes disclosed in Note 8. The amendments deleted portions of the notes that originally provided for a conversion formula used to determine the conversion price per share, and deletes provisions for the repayment of the notes through sales of the Company’s registered shares to Tangiers .

 

We previously reported an expense payable to New Era CPAs, an accounting firm in which Antonio Migliarese, the Company’s former Chief Financial Officer, is a partner. The expense is payable in common stock. As of June 30, 2016 the Company owed Mr. Migliarese 77,660 shares, reflected as a liability. On July 29, 2016 the Company issued 77,660 shares due Mr. Migliarese.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate these estimates, including those related to useful lives of real estate assets, cost reimbursement income, bad debts, impairment, net lease intangibles, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

Background

 

American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and manage a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. We are a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

 

We were incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.

 

 

Results of Operations: 

      For the three months ended  June 30, 2016       % of Revenues       For the three months ended  June 30, 2015       % of Revenues       $ Change  
Revenues                                        
     Consulting Services   $ 211,863       47.8     $ 268,488       57.3     ($ 56,625 )
     Product and equipment     231,785       52.2       200,257       42.7       31,528  
Total Revenues     443,648       100.0       468,745       100.0       (25,097 )
                                         
Cost of Revenues                                        
     Cost of consulting services     51,278       11.6       88,632       18.9       (37,354 )
     Cost of products and equipment     145,848       32.9       176,347       37.6       (30,499 )
Total Cost of Revenues     197,126       44.4       264,979       56.5       (67,853 )
                                         
Gross Profit     246,522       55.6       203,766       43.5       42,756  
                                         
Operating expenses                                        
     General and administrative     307,953       69.4       130,454       27.8       177,499  
     Investor Relations     893       0.2       56,286       12.0       (55,393 )
     Selling and marketing     19,662       4.4       113,224       24.2       (93,562 )
     Research and development     1,413       0.3       11,350       2.4       (9,937 )
Total Operating expenses     329,921       74.4       311,314       66.4       18,607  
                                         
Loss from Operations     (83,399 )     (18.8 )     (107,548 )     (22.9 )     24,149  
                                         
Other Income (expense)                                        
     Loss on debt extinguishment     0       0.0       72,771       15.5       (72,771 )
     Interest Income (expense)     (1,376 )     (0.3 )     (8,837 )     (1.9 )     7,461  
Total Other Income (expense)     (1,376 )     (0.3 )     63,934       13.6       (65,310 )
                                         
Net Loss before taxes     (84,775 )     (19.1 )     (43,614 )     (9.3 )     (41,161 )
Income Tax expense (benefit)     0       0.0       0       0.0       0  
                                         
NET LOSS   ($ 84,775 )     (19.1 )   ($ 43,614 )     (9.3 )   ($ 41,161 )

 

Revenues 

Total revenues were $443,648 for the three months ended June 30, 2016, compared to $468,745 for the three months ended June 30, 2015, a decrease of $25,097. The decrease in consulting revenues is due to our consulting clients being in various early stages of their projects, which results in periodic fluctuations of cyclical consulting revenues as of June 30, 2016 and June 30, 2015. However, we did continue to grow in the product and equipment sales as our ongoing clients required products for their strategic growth and development. We expect to see growth in the future as more states allow for the medical and recreational use and sale of cannabis. We continue to establish our products and equipment offerings and growth in our client base and volume of operations as our business has matures following commencement of business operations in April 2013. For the three months ended June 30, 2016, consulting services revenue were $211,863, or 47.8% of total revenue, compared to $268,488, or 57.3% of total revenues for the three months ended June 30, 2015. This is mainly attributed to fewer new clients on board for the three months ended June 30, 2016 compared to the three months ended June 30, 2015. For the three months ended June 30, 2016, products and equipment revenue were $231,785, or 52.2% of total revenues, compared to $200,257, or 42.7% of total revenues for the three months ended June 30, 2015.

 

Costs of Revenues 

Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the three months ended June 30, 2016, our total costs of revenues were $197,126, or 44.4% of total revenues. This compares to total costs of revenues for the three months ended June 30, 2015 of $264,979 or 56.5% of total revenues. The decrease in costs of revenues of $67,853 was primarily due to a decrease in consulting sales volume   discussed above and a reduction in our internal infrastructure development. For the three months ended June 30, 2016, consulting-related costs were $51,278, or 11.6% of total revenue, as compared to costs of $88,632, or 18.9% of revenue for the three months ended June 30, 2015. Costs associated with products and equipment were $145,848, or 32.9% of total revenue for the three months ended June 30, 2016 as compared to $176,347, or 37.6% of total revenue for the three months ended June 30, 2015. As a percentage of revenues, the decreases were primarily due to lower sales volume during the three months ended June 30, 2016, as certain primarily-fixed costs such as labor made up a comparably smaller percentage of revenues as compared to the three months ended June 30, 2015.

 

Gross Profit

Total gross profit was $246,522 for the three months ended June 30, 2016, comprised of consulting services gross profit of $160,585 and products and equipment gross profit of $85,937. This compares to total gross profit of $203,766 for the three months ended June 30, 2015, comprised of consulting services gross profit of $179,856 and products and equipment gross profit of $23,910. These decrease of $19,271 for consulting services gross profit and an increase of $62,027 for products and equipment gross profit were primarily due to less new clients in our client base and further establishment of our products and equipment offerings. As a percentage of total revenues, gross profit was 56.6% for the three months ended June 30, 2016 and 43.5% for the three months ended June 30, 2015. This increase was primarily driven by the higher sales volume in products and equipment sales volume during the three months ended June 30, 2016.

 

Operating Expenses

Total operating expenses were $329,921, or 74.4% of total revenues for the three months ended June 30, 2016, compared to $311,314, or 66.4% of total revenues for the three months ended June 30, 2015. This increase was primarily due to an increase in general and administrative expenses attributable to higher bad debt expense and by higher accounting, auditing and legal fees associated with the costs of running a public company. The increase was further driven by higher payroll costs as lower labor amounts were allocated to projects for the three months ended June 30, 2016 as compared to June 30, 2015. Also, the Company has reduced selling and marketing efforts due to achieving a stronger brand recognition in the market place during the three months ended June 30, 2016 as compared with the three months ended June 30, 2015, which has resulted in lower expenditures for trade shows and conferences.

 

Other Income (Expense) 

Other income (expense) for the three months ended June 30, 2016 was expense of $1,376 as compared with $63,934 income for the three months ended June 30, 2015. For the three months ended June 30, 2016 the Company incurred a non-cash interest expense reflecting $2,076 related to convertible notes payable discount amortization for the period, which was partially offset by other income as compared to $8,837 expense for the three months ended June 30, 2015. aThe Company incurred a gain on extinguishment of debt of $72,771 for the three months ended June 30, 2015.

 

Income Tax Expense (Benefit)

Although our tax status changed from a non-taxable pass-through entity (S-Corporation) to a taxable entity (C-Corporation) during the year ended December 31, 2014, due to cumulative losses since we became a C-Corporation, we recorded a valuation allowance against our related deferred tax asset which netted our deferred tax asset and benefit for income taxes to zero for the three months ended June 30, 2016.

 

Net Income (Loss)

As a result of the factors discussed above, net income (expense) for the three months ended June 30, 2016 was net loss of $84,775, or 19.1% of total revenues for the period, as compared to a net loss of $43,614, or 9.3% of total revenues for the three months ended June 30, 2015.

 

Results of Operations:

 

      For the six months ended  June 30, 2016       % of Revenues       For the six months ended  June 30, 2015       % of Revenues       $ Change  
Revenues                                        
     Consulting Services   $ 459,473       46.7     $ 464,058       50.9     ($ 4,585 )
     Product and equipment     524,579       53.3       448,354       49.1       76,225  
Total Revenues     984,052       100.0       912,412       100.0       71,640  
                                         
Cost of Revenues                                        
     Cost of consulting services     99,800       10.1       146,483       16.1       (46,683 )
     Cost of products and equipment     380,857       38.7       401,998       44.1       (21,141 )
Total Cost of Revenues     480,657       48.8       548,481       60.1       (67,824 )
                                         
Gross Profit     503,395       51.2       363,931       39.9       139,464  
                                         
Operating expenses                                        
     General and administrative     531,440       54.0       252,578       27.7       278,862  
     Investor Relations     18,068       1.8       187,702       20.6       (169,634 )
     Selling and marketing     40,477       4.1       207,529       22.7       (167,052 )
     Research and development     1,413       0.1       41,722       4.6       (40,309 )
Total Operating expenses     591,398       60.1       689,531       75.6       (98,133 )
                                         
Loss from Operations     (88,003 )     (8.9 )     (325,600 )     (35.7 )     237,597  
                                         
Other Income (expense)                                        
     Loss on debt extinguishment     0       0.0       72,771       8.0       (72,771 )
     Interest Income (expense)     (10,329 )     (1.0 )     (17,623 )     (1.9 )     7,294  
Total Other Income (expense)     (10,329 )     (1.0 )     55,148       6.0       (65,477 )
                                         
Net Loss before taxes     (98,332 )     (10.0 )     (270,452 )     (29.6 )     172,120  
Income Tax expense (benefit)     0       0.0       0       0.0       0  
                                         
NET LOSS   ($ 98,332 )     (10.0 )   ($ 270,452 )     (29.6 )   $ 172,120  

 

 

Revenues 

Total revenues were $984,052 for the six months ended June 30, 2016, compared to $912,412 for the six months ended June 30, 2015, an increase of $71,640. This increase was driven by growth in our sales of products and equipment as our business matured following commencement of business operations in April 2013. For the six months ended June 30, 2016, consulting services revenue was $459,473, or 46.7% of total revenue, compared to $464,058, or 50.9% of total revenues for the six months ended June 30, 2015. This reduction is mainly due to fewer new clients for the six months ended June 30, 2016 as compared with the six months ended June 30, 2015. For the six months ended June 30, 2016, products and equipment revenue were $524,579, or 53.3% of total revenues, compared to $448,354, or 49.1% of total revenues for the six months ended June 30, 2015.

 

Costs of Revenues 

Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the six months ended June 30, 2016, our total costs of revenues were $480,657, or 48.8% of total revenues. This compares to total costs of revenues for the six months ended June 30, 2015 of $548,481 or 60.1% of total revenues. The decrease in costs of revenues of $67,824 was primarily due to the overall increase in sales volume discussed above and a reduction in our internal infrastructure development. For the six months ended June 30, 2016, consulting-related costs were $99,800, or 10.1% of total revenue, as compared to costs of $146,483 or 16.1% of revenue for the six months ended June 30, 2015. Costs associated with products and equipment were $380,857, or 38.1% of total revenue for the six months ended June 30, 2016 as compared to $401,998, or 44.1% of total revenue for the six months ended June 30, 2015. As a percentage of revenues, the decreases were primarily due to level of sales volume, as discussed above, during the six months ended June 30, 2016, as certain labor intensive services made up a comparably smaller percentage of revenues as compared to the six months ended June 30, 2015.

 

Gross Profit

Total gross profit was $503,395 for the six months ended June 30, 2016, comprised of consulting services gross profit of $359,673 and products and equipment gross profit of $143,723. This compares to total gross profit of $363,931 for the six months ended June 30, 2015, comprised of consulting services gross profit of $317,575 and products and equipment gross profit of $46,356. These increases of $42,098 in consulting services gross profit and $97,367 in products and equipment gross profit were primarily due to lower labor intensive services on the consulting revenues, and growth in sales of our products and equipment offerings. As a percentage of total revenues, gross profit was 51.2% for the six months ended June 30, 2016 and 39.9% for the six months ended June 30, 2016. This increase was primarily due to higher sales volume during the six months ended June 30, 2016.

 

Operating Expenses

Total operating expenses were $591,398, or 60.1% of total revenues for the six months ended June 30, 2016, compared to $689,531, or 75.6% of total revenues for the six months ended June 30, 2015. This decrease was primarily due to a decrease in investor relations expenses as the Company is currently utilizing internal resources for this function instead of outside sources; also the Company has not invested in research and development projects during the six months ended June 30, 2016. In addition, the Company has reduced selling and marketing efforts due to achieving a stronger brand recognition in the market place during the six months ended 2016, which has resulted in lower expenditures for trade shows and conferences as compared to the six months ended June 30, 2015. However, there was an increase in general and administrative expenses which was attributed to bad debts expense in 2016 for which there was $0 in 2015, along with increase in professional fees such as accounting, auditing and legal services, which are all needed to run a public company, as well as an increase in payroll costs as the Company allocated less labor to projects for the six months ended June 30, 2016 as compared to June 30, 2015.

 

Other Income (Expense) 

Other income (expense) for the six months ended June 30, 2016 was expense of $10,329 as compared with income of $55,148 for the six months ended June 30, 2015. For the six months ended June 30, 2016 the Company incurred non-cash interest expense reflecting $10,329 related to convertible notes payable discount amortization for the period, which was partially offset by interest income as compared to $17,623 expense for the six months ended June 30, 2015. The Company recognized a gain on extinguishment of debt of $72,771 for the six months ended June 30, 2015.

 

Income Tax Expense (Benefit)

Although our tax status changed from a non-taxable pass-through entity (S-Corporation) to a taxable entity (C-Corporation) during the year ended December 31, 2014, due to cumulative losses since we became a C-Corporation, we recorded a valuation allowance against our related deferred tax asset which netted our deferred tax asset and benefit for income taxes to zero for the six months ended June 30, 2016.

 

Net Income (Loss)

As a result of the factors discussed above, net loss for the six months ended June 30, 2016 was $98,332 or 10.0% of total revenues and net loss for the six months ended June 30, 2015 was $270,452 or 29.6% of total revenues.

 

Liquidity and Capital Resources

As of June 30, 2016, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $228,654 and accounts receivable of $151,736. We also have the ability to raise additional capital as needed through external equity financing transactions. For the six months ended June 30, 2016, primarily as a result of non-cash expenses, the Company’s operating cash flows were a use of $464,529 due to an increase in accounts receivable of $116,795, a decrease in advances from clients of $105,416 and a decrease in accounts payable of $146,491. Additionally, considering that our fixed overhead costs are low, we have the ability to issue stock to compensate employees and management, and the level of future revenue we expect to generate from executed client contracts, we believe our liquidity and capital resources to be adequate to fund our operational and general and administrative expenses for at least the next 12 months without needing to raise additional debt or equity funding. There is no guarantee we will have the ability to raise additional capital as needed through external equity financing transactions if required.

 

Operating Activities

Net cash used in operating activities for the six months June 30, 2016 and 2015 was $464,529 and $175,368, respectively. The $464,529 use of cash was due to an increase in accounts receivable of $116,795, a decrease in advances from clients of $105,416 and a decrease in accounts payable of $146.491. Net cash used in operating activities for the six months ended June 30, 2015 was $175,368, consisting of net loss of $270,452, non-cash adjustments reconciling net income to net cash used in operating activities of $134,186 and a net use of cash of $39,102 from changes in operating assets and liabilities. The net non-cash adjustments of $134,186 were due to amortization of the discount on convertible notes payable of $17,704, employee stock-based compensation of $80,394, professional services compensated in shares of common stock of $107,385 and depreciation of $1,474, partially offset by a gain on debt extinguishment related to a negotiated settlement of legal fees of $72,771. Changes in operating assets and liabilities, a net use of cash of $39,102, were the result of a decrease in deferred revenue of $144,115, an increase in accounts receivable of $44,842 on higher sales volume, an increase in inventory of $25,600 primarily related to Satchels, an increase in prepaid expenses and other current assets of $5,606 and a decrease in accrued and other current liabilities of $1,511, mostly offset by a decrease in deposits of $102,202 primarily due to the receipt of Satchels during the period and an increase in accounts payable of $80,370.

 

Investing Activities

For the six months ended June 30, 2016 and 2015, investing activities were a use of cash of $1,662 and $12,332, respectively. This was due to purchases of office furniture and computer equipment during the six months ended June 30, 2016 and 2015, respectively.

 

Financing Activities

For the six months ended June 30, 2016 and 2015, the net cash from financing activities was $139,065 and $250,000, respectively. During the six months ended June 30, 2016 the Company received proceeds of $139,065 from  one convertible promissory note. Net cash provided by financing activities of $250,000 for the six months ended June 30, 2015 reflected the sale of 833,333 shares of common stock to an investor during the period.

  

Off Balance Sheet Arrangements

 

As of June 30, 2016 and December 31, 2015, we did not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Non-GAAP Financial Measures

 

We use Adjusted EBITA, a non-GAAP metric, to monitor our overall business performance. We define Adjusted EBITA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation and certain non-recurring expenses, which to date have been limited to costs associated with the Reverse Merger. We believe that such adjustments to arrive at Adjusted EBITA provides us with a more comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in the evaluation of our Company.

 

A reconciliation of net income (loss) to Adjusted EBITA is provided below.

 

      For three months ended June 30, 2016       For three months ended June 30, 2015       For six months ended June 30, 2016       For six months ended June 30, 2015  
Adjusted EBITA reconciliation:                                
Net income (los)   ($ 84,775 )   ($ 43,614 )   ($ 98,332 )   ($ 270,425 )
Interest expenese (loss)     1,376       8,837       10,329       17,623  
Tax expense (benefit)     0       0       0       0  
Stock-based compensation expense     12991       80,667       23,620       187,779  
Reverse merger-related expenses     0       0                  
Adjusted EBITA   $ (68,408 )     45,890     ($ 64,383 )   $ 65,050  

ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management of the Company is responsible for maintaining disclosure controls and procedures that are designed to ensure that financial information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the timeframes specified in the Securities and Exchange Commission’s rules and forms, consistent with Items 307 and 308 of Regulation S-K.

 

In addition, the disclosure controls and procedures must ensure that such financial information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

 

As of March 31, 2016, an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) was carried out under the supervision and with the participation of our Chief Executive Officer, Chief Financial Officer, and other persons carrying out similar functions for the Company. Based on the evaluation of the Company’s disclosure controls and procedures, the Company concluded that during the period covered by this report, such disclosure controls and procedures were not effective.

 

The Company continues to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, the Company evaluates and assesses its internal controls and procedures regarding its financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary and on an on-going basis.

 

Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of the prevention or detection of misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Controls

 

 

The Company had no reportable changes to its internal controls over financial reporting for the period covered by this report. 

 

The Company will continually enhance and test its internal controls over financial reporting on a continuing basis. Additionally, the Company’s management, under the control of its Chief Executive Officer and Chief Financial Officer, will increase its review of its disclosure controls and procedures on an ongoing basis. Finally, the Company plans to designate, in conjunction with its Chief Financial Officer, individuals responsible for identifying reportable developments and the process for resolving compliance issues related to them. The Company believes these actions will focus necessary attention and resources in its internal accounting functions.

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On January 20, 2016, we were named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit sought damages of $100,000 related to an employment contract. The Company filed a motion to dismiss the case based upon the employment contract, which required mandatory contractual arbitration of disputes. On May 18, 2016 the Circuit Court of Cook County, Illinois granted the Company’s motion and the case was dismissed. No pending arbitration claims have been pursued by Mr. Baroud as of the date of this filing.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

No transactions meeting the reporting requirements of this item occurred during the periods covered by this report.

 

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

No senior securities were issued and outstanding during the three months ended March 31, 2016 or 2015.

  

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

This list is intended to constitute the exhibit index.

 

10.1 Amended and Restated Investment Agreement dated August 4, 2016 between the Company and Tangiers Global, LLC.

 

10.2 Amended and Restated Registration Rights Agreement dated August 4, 2016 between the Company and Tangiers Global, LLC.

 

31.1 Certification of Principal Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

31.2 Certification of Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

32.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

32.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS XBRL Instance Document*

 

101.SCH XBRL Taxonomy Extension Schema Document*

 

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document*

 

101.DEF XBRL Taxonomy Extension Definition Linkbase Document*

 

101.LAB XBRL Taxonomy Extension Label Linkbase Document*

 

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document*

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

American Cannabis Company, Inc.

 

Date: August 17, 2016

By: /s/Corey Hollister

Corey Hollister, Chief Executive Officer

(Principal Executive Officer)

 

Date: August 17, 2016

By: /s/ Jesus Quintero

Jesus Quintero, Chief Financial Officer

(Principal Financial Officer)